rsm
Well-known member
A prostate cancer drug, Xtandi, was developed by Pfizer and Astellas using US tax payer funds for 100% of the funding to develop the drug.
In the US, a one year supply of Xtandi currently costs $189,800.
It costs 3 to 6 times more in the US than any other country.
Our tax dollars at work, for everyone else except American serfs.
In the US, a one year supply of Xtandi currently costs $189,800.
It costs 3 to 6 times more in the US than any other country.
Our tax dollars at work, for everyone else except American serfs.